Mitral valve prolapse in the general population
the benign nature of echocardiographic features in the Framingham Heart Study
Lisa A. Freed, MD, FACC*
,
Emelia J. Benjamin, MD, ScM, FACC*
||,
Daniel Levy, MD, FACC*
||¶#,
Martin G. Larson, ScD*||,
Jane C. Evans, DSc*||,
Deborah L. Fuller, RDCS*,
Birgitta Lehman, RDCS* and
Robert A. Levine, MD, FACC
,*
* National Heart, Lung, and Blood Institutes Framingham Heart Study, Framingham, Massachusetts, USA
Cardiac Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
Harvard Medical School, Boston, Massachusetts, USA
Cardiology, Boston University School of Medicine, Boston, Massachusetts, USA
|| Epidemiology and Preventive Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
¶ National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA
# Divisions of Cardiology and Clinical Epidemiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

View larger version (35K):
[in a new window]
|
Figure 1 The distribution of mitral regurgitation severity among the subjects in the study. MVP = mitral valve prolapse.
|
|
Copyright © 2002 by the American College of Cardiology Foundation.